Cargando…

A cross-sectional investigation of the impact of COVID-19 on community pharmacy

BACKGROUND: COVID-19 caused Australian government and state legislative/regulatory changes which impacted directly on aspects of professional community pharmacy. OBJECTIVES: To examine the views and experiences of community pharmacists regarding the impact of COVID-19 on professional pharmacy servic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gicic, Amin, Li, Shiyi, Amini, Shabnam, Sim, Tin Fei, White, Christianne, Sunderland, Bruce, Czarniak, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159746/
https://www.ncbi.nlm.nih.gov/pubmed/35669700
http://dx.doi.org/10.1016/j.rcsop.2022.100145
_version_ 1784719119887630336
author Gicic, Amin
Li, Shiyi
Amini, Shabnam
Sim, Tin Fei
White, Christianne
Sunderland, Bruce
Czarniak, Petra
author_facet Gicic, Amin
Li, Shiyi
Amini, Shabnam
Sim, Tin Fei
White, Christianne
Sunderland, Bruce
Czarniak, Petra
author_sort Gicic, Amin
collection PubMed
description BACKGROUND: COVID-19 caused Australian government and state legislative/regulatory changes which impacted directly on aspects of professional community pharmacy. OBJECTIVES: To examine the views and experiences of community pharmacists regarding the impact of COVID-19 on professional pharmacy services in Western Australian community pharmacies. METHODS: A Qualtrics questionnaire link was emailed to all 668 community pharmacies in Western Australia in March 2021. Data were collected on the impact of COVID-19 on professional pharmacy services (telehealth, digital image prescriptions, continued dispensing and emergency supply, home delivery services, medicine and medical resource substitutions), the pharmacy environment (work hours) and professional pharmacy structure (staffing and any measures implemented). Questions included 5-point Likert responses as well as yes/no or option responses. Descriptive statistics were used to summarise questionnaire responses. Chi Squared analysis was used to investigate differences between metropolitan and rural community pharmacies. RESULTS: The response rate was 97/668 (14.5%). Many pharmacies belonged to banner groups (47/95; 40.5%). Use of telehealth was reported (25/96; 26.0%), most commonly for MedsChecks. Many received digital image prescriptions (83/88; 94.3%) and continued dispensing, emergency supply requests, or both (78/84; 92.9%) daily. For home deliveries, most used pharmacy staff (56/78; 71.8%). Shortages were reported for many medicines. Panic buying/stock-piling and the media contributed to increased panic and shortages. Little change occurred in trading hours although many reported increased workloads (67/75; 89.3%). CONCLUSIONS: Covid-19 has fast-tracked digitisation in Western Australian community pharmacies. This change is likely similar in other parts of Australia. This was facilitated through the expedition of regulatory changes to enable digital health. Whilst electronic prescribing has progressed, telehealth in pharmacy remained underutilised. The pandemic has contributed to pronounced medicine and medical resources shortages, which increased the workloads and pressure of community pharmacists. Pharmacists were confronted with a lot of legislative change in a short period of time. There is a need for clear and concise communication from all levels of government in future pandemics.
format Online
Article
Text
id pubmed-9159746
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-91597462022-06-02 A cross-sectional investigation of the impact of COVID-19 on community pharmacy Gicic, Amin Li, Shiyi Amini, Shabnam Sim, Tin Fei White, Christianne Sunderland, Bruce Czarniak, Petra Explor Res Clin Soc Pharm Article BACKGROUND: COVID-19 caused Australian government and state legislative/regulatory changes which impacted directly on aspects of professional community pharmacy. OBJECTIVES: To examine the views and experiences of community pharmacists regarding the impact of COVID-19 on professional pharmacy services in Western Australian community pharmacies. METHODS: A Qualtrics questionnaire link was emailed to all 668 community pharmacies in Western Australia in March 2021. Data were collected on the impact of COVID-19 on professional pharmacy services (telehealth, digital image prescriptions, continued dispensing and emergency supply, home delivery services, medicine and medical resource substitutions), the pharmacy environment (work hours) and professional pharmacy structure (staffing and any measures implemented). Questions included 5-point Likert responses as well as yes/no or option responses. Descriptive statistics were used to summarise questionnaire responses. Chi Squared analysis was used to investigate differences between metropolitan and rural community pharmacies. RESULTS: The response rate was 97/668 (14.5%). Many pharmacies belonged to banner groups (47/95; 40.5%). Use of telehealth was reported (25/96; 26.0%), most commonly for MedsChecks. Many received digital image prescriptions (83/88; 94.3%) and continued dispensing, emergency supply requests, or both (78/84; 92.9%) daily. For home deliveries, most used pharmacy staff (56/78; 71.8%). Shortages were reported for many medicines. Panic buying/stock-piling and the media contributed to increased panic and shortages. Little change occurred in trading hours although many reported increased workloads (67/75; 89.3%). CONCLUSIONS: Covid-19 has fast-tracked digitisation in Western Australian community pharmacies. This change is likely similar in other parts of Australia. This was facilitated through the expedition of regulatory changes to enable digital health. Whilst electronic prescribing has progressed, telehealth in pharmacy remained underutilised. The pandemic has contributed to pronounced medicine and medical resources shortages, which increased the workloads and pressure of community pharmacists. Pharmacists were confronted with a lot of legislative change in a short period of time. There is a need for clear and concise communication from all levels of government in future pandemics. The Authors. Published by Elsevier Inc. 2022-06 2022-05-18 /pmc/articles/PMC9159746/ /pubmed/35669700 http://dx.doi.org/10.1016/j.rcsop.2022.100145 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gicic, Amin
Li, Shiyi
Amini, Shabnam
Sim, Tin Fei
White, Christianne
Sunderland, Bruce
Czarniak, Petra
A cross-sectional investigation of the impact of COVID-19 on community pharmacy
title A cross-sectional investigation of the impact of COVID-19 on community pharmacy
title_full A cross-sectional investigation of the impact of COVID-19 on community pharmacy
title_fullStr A cross-sectional investigation of the impact of COVID-19 on community pharmacy
title_full_unstemmed A cross-sectional investigation of the impact of COVID-19 on community pharmacy
title_short A cross-sectional investigation of the impact of COVID-19 on community pharmacy
title_sort cross-sectional investigation of the impact of covid-19 on community pharmacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159746/
https://www.ncbi.nlm.nih.gov/pubmed/35669700
http://dx.doi.org/10.1016/j.rcsop.2022.100145
work_keys_str_mv AT gicicamin acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT lishiyi acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT aminishabnam acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT simtinfei acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT whitechristianne acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT sunderlandbruce acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT czarniakpetra acrosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT gicicamin crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT lishiyi crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT aminishabnam crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT simtinfei crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT whitechristianne crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT sunderlandbruce crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy
AT czarniakpetra crosssectionalinvestigationoftheimpactofcovid19oncommunitypharmacy